fbpx
  • Home
  • Study Details
Not currently enrolling

Continuous Glucose Monitoring in T2D Basal Insulin Users: The MOBILE Study

The primary purpose of this research is to assess the benefit on glycemic control, using real time continuous glucose (CGM) versus self monitored blood glucose (SMBG/finger sticks), in persons with Type 2 Diabetes (T2D) taking basal insulin (long-acting) with or without oral medications and/or GLP-1 analogue, not at their HbA1c goal. Secondary objectives are to assess quality of life benefits of RT-CGM and to assess frequency of hypoglycemia. The Phase 2 primary objective is to determine if glycemic control worsens upon withdrawal of RT-CGM. Secondary objectives are to determine if glycemic benefits of RT-CGM use are sustainable for a long period of time (14 months), to assess QoL benefits of continuing or discontinuing RT-CGM, and to assess frequency of hypoglycemia.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female

Contact the Team

Location

Thank you for your interest, but this study is not currently enrolling.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Laura Young
Medicine-Endocrinology

Study Topics

Diabetes

IRB Number

18-2013

logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.